Año: 2018
Journal Impact Factor (JIF): 14.1960
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
ONCOLOGY | SCIE | 9/230 | Q1 | T1 | D1 |
Año: 2018
Journal Citation Indicator (JCI): 2,780
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
ONCOLOGY | 9/302 | Q1 | T1 | D1 | 97,19 |
Año:
2018
CiteScore:
20,400
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Hematology | 2/122 | Q1 | T1 | D1 |
Oncology | 9/323 | Q1 | T1 | D1 |
SJR año:
2018
Factor de Impacto:
6,047
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Hematology | 3/142 | Q1 | T1 | D1 |
Medicine (miscellaneous) | 33/2805 | Q1 | T1 | D1 |
Oncology | 8/401 | Q1 | T1 | D1 |
Agencia | Código de Proyecto |
---|---|
Celgene Corporation | - |
# | Autor | Afiliación |
---|---|---|
1 | Sarah Cannon Research Institute (United States) | |
2 | Coleman, R | The University of Sheffield (United Kingdom) |
3 | Conte, P | Università degli Studi di Padova (Italy) |
4 | Cortes, J | Hospital Ramon y Cajal; Vall d‘Hebron Institut de Oncologia (Spain) |
5 | Brufsky, A | University of Pittsburgh School of Medicine (United States) |
6 | Shtivelband, M | Medical Oncology (United States) |
7 | Young, R | Medical Oncology (United States) |
8 | Bengala, C | Misericordia Town Hospital (Italy) |
9 | Ali, H | Henry Ford Health System (United States) |
10 | Eakel, J | Oncology Hematology Consultants (United States) |
11 | Schneeweiss, A | Universitätsklinikum Heidelberg (Germany) |
12 | de la Cruz-Merino, L | Hospital Universitario Virgen Macarena (Spain) |
13 | Wilks, S | Texas Oncology (United States) |
14 | O'Shaughnessy, J | Texas Oncology (United States) |
15 | Gluck, S | Celgene Corporation (United States) |
16 | Li, H | Celgene Corporation (United States) |
17 | Miller, J | Celgene Corporation (United States) |
18 | Barton, D | Celgene Corporation (United States) |
19 | Harbeck, N | Ludwig-Maximilians-Universität München (Germany) |